Holdings of Affinity Asset Advisors, LLC

Name: Holdings of Affinity Asset Advisors, LLC
Creator: Titelia

76 declared positions · as of Mar 31, 2026

Original filing · Ten largest lines: 46.5 % of the equity sleeve

Sector breakdown

Health care 5.8 %
Unattributed 94.2 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

US 90.7 %
FR 3.3 %
IL 3.1 %
DK 1.6 %
KY 0.8 %
GB 0.4 %

Shares computed on the equity sleeve.

Rank	Country	Lines	Value	Share
1	US	70	1.2B $	90.71 %
2	FR	1	45.1M $	3.31 %
3	IL	1	42.2M $	3.09 %
4	DK	1	21.7M $	1.59 %
5	KY	2	11.5M $	0.84 %
6	GB	1	6.1M $	0.45 %

Positions

Rank	Company	Shares	Value
1	Apogee Therapeutics Inc	1,284,926	108.2M $
2	Erasca Inc	5,350,000	86.6M $
3	Insmed Inc	480,000	78.5M $
4	Spyre Therapeutics Inc	1,279,134	64.5M $
5	CENTESSA PHARMACEUTICALS PLC	1,400,000	55.6M $
6	Praxis Precision Medicines Inc	170,000	54.8M $
7	AnaptysBio Inc	940,000	52.1M $
8	Cytokinetics Inc	700,483	46.2M $
9	Abivax SA	405,000	45.1M $
10	Teva Pharmaceutical Industries Ltd	1,400,000	42.2M $
11	Arcellx Inc	362,764	41.7M $
12	Nuvalent Inc	300,000	30.7M $
13	Terns Pharmaceuticals Inc	562,631	29.7M $
14	Dianthus Therapeutics Inc	350,000	29.4M $
15	Lexeo Therapeutics Inc	5,050,211	29M $
16	Cogent Biosciences Inc	750,000	28.9M $
17	Madrigal Pharmaceuticals Inc	55,000	28.8M $
18	Sutro Biopharma Inc	1,069,519	26.6M $
19	Forte Biosciences Inc	1,011,890	26.2M $
20	Oruka Therapeutics Inc	499,673	24.5M $
21	Trevi Therapeutics Inc	2,000,172	23.9M $
22	Ovid therapeutics Inc	10,636,318	23.6M $
23	Enliven Therapeutics Inc	586,904	23M $
24	Ascendis Pharma A/S	95,000	21.7M $
25	Mineralys Therapeutics Inc	750,000	20.3M $
26	AVALO THERAPEUTICS INC	1,340,840	20M $
27	Protagonist Therapeutics Inc	172,125	18.1M $
28	Celldex Therapeutics Inc	500,000	15.9M $
29	Nurix Therapeutics Inc	967,620	15M $
30	Savara Inc	2,512,153	13.7M $
31	Perspective Therapeutics Inc	3,164,582	13.2M $
32	Arrowhead Pharmaceuticals Inc	200,000	12.5M $
33	DAMORA THERAPEUTICS INC	450,000	11.7M $
34	Alto Neuroscience Inc	500,000	11.2M $
35	Bridgebio Pharma Inc	150,000	11.1M $
36	Cullinan Therapeutics Inc	781,260	11.1M $
37	Belite Bio Inc	65,000	10.4M $
38	Vera Therapeutics Inc	250,000	10.1M $
39	Tyra Biosciences Inc	257,512	9.9M $
40	Revolution Medicines Inc	100,000	9.7M $
41	JADE BIOSCIENCES INC	639,956	9M $
42	Travere Therapeutics Inc	300,000	8.9M $
43	Korro Bio Inc	706,904	8M $
44	SpyGlass Pharma Inc	250,000	6.5M $
45	Compass Pathways plc	1,108,483	6.1M $
46	IBIO INC	3,107,200	5.9M $
47	Anteris Technologies Global Corp	912,397	5.1M $
48	Viridian Therapeutics Inc	250,000	4.9M $
49	Climb Bio Inc	700,000	4.8M $
50	Rezolute Inc	1,547,641	4.7M $
51	Sagimet Biosciences Inc	868,020	4.5M $
52	MBX Biosciences Inc	150,000	4.5M $
53	Taysha Gene Therapies Inc	1,000,000	4.5M $
54	VeraDermics Inc	70,000	4.4M $
55	Generate Biomedicines Inc	350,000	4.4M $
56	ArriVent Biopharma Inc	175,000	4M $
57	Relay Therapeutics Inc	400,000	4M $
58	Verrica Pharmaceuticals Inc	707,338	3.7M $
59	Precision BioSciences Inc	597,946	3.3M $
60	Karyopharm Therapeutics Inc	500,000	2.8M $
61	Crinetics Pharmaceuticals Inc	75,000	2.7M $
62	NextCure Inc	241,826	2.6M $
63	Immunovant Inc	100,000	2.5M $
64	Equillium Inc	1,226,310	2.5M $
65	SAB Biotherapeutics Inc	575,000	2.2M $
66	Corcept Therapeutics Inc	50,000	2M $
67	Orchestra BioMed Holdings Inc	402,550	1.7M $
68	Kezar Life Sciences Inc	229,076	1.7M $
69	MacroGenics Inc	500,000	1.4M $
70	Adlai Nortye Ltd.	164,748	1.1M $
71	Alector Inc	500,000	1.1M $
72	OnKure Therapeutics Inc	240,963	997.6K $
73	LENZ Therapeutics Inc	100,000	915K $
74	X4 PHARMACEUTICALS INC	145,000	598.9K $
75	Q32 Bio Inc	27,777	178.3K $
76	ADAGIO MEDICAL HOLDINGS INC	80,000	92K $